Aristotle Capital Boston, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aristotle Capital Boston, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,752,634
-6.2%
1,187,981
+2.2%
1.06%
+0.8%
Q2 2023$34,928,115
-16.5%
1,161,947
+0.6%
1.05%
-19.0%
Q1 2023$41,851,071
+4.1%
1,155,149
+2.5%
1.29%
+2.1%
Q4 2022$40,195,845
+2.6%
1,126,881
-2.6%
1.27%
-4.3%
Q3 2022$39,183,000
+6.9%
1,157,553
-8.7%
1.32%
+21.1%
Q2 2022$36,663,000
-9.8%
1,267,740
+0.8%
1.09%
+6.5%
Q1 2022$40,661,000
+8.4%
1,258,067
-2.2%
1.03%
+16.8%
Q4 2021$37,496,000
+6.7%
1,285,872
-2.4%
0.88%
+6.5%
Q3 2021$35,154,000
+7.5%
1,318,109
+24.2%
0.82%
+10.3%
Q2 2021$32,688,000
+28.3%
1,061,653
+9.1%
0.75%
+31.9%
Q1 2021$25,481,000
-0.9%
973,293
-4.7%
0.57%
-6.9%
Q4 2020$25,704,000
+15.0%
1,021,626
-4.7%
0.61%
-6.0%
Q3 2020$22,350,000
-8.4%
1,072,452
+4.3%
0.65%
-12.7%
Q2 2020$24,411,000
+83.2%
1,027,838
+38.8%
0.74%
+30.2%
Q1 2020$13,324,000
-25.8%
740,639
-2.2%
0.57%
+15.2%
Q4 2019$17,968,000
-12.1%
757,503
+1.8%
0.50%
-17.4%
Q3 2019$20,445,000
+494.0%
743,992
+615.2%
0.60%
+459.8%
Q2 2019$3,442,000104,0310.11%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders